Public procurers in ProEmpower will address the challenge of a diabetes pandemic by procuring a disease self-management solution that will make person-centred care a reality. The project assumes that the quality of medical decisions can be enhanced by personalised decision support tools that summarise patient clinical characteristics, treatment preference and ancillary data at the point of care. Early detection, personal decision support, self management and peer support are to be delivered from a platform with full interoperable and secure access to the necessary devices and health records. In this way a quality culture in healthcare will be fostered and learning healthcare systems will be made reality.
Fully rolled out in the four countries, enabled by procurers with the authority and capacity in their countries and regions, ProEmpower will serve 12 million diabetes patients. Reductions in diabetes-related death, amputation, blindness and renal failure promise cost relief of € 53 billion over 7 years in the four countries. Suppliers can expect a turnover of € 5 billion a year. Proven ability to cover the four different health systems promises ProEmpower suppliers easy entry onto other EU markets and beyond, a very strong contribution to overcoming fragmentation of demand and fostering the global market
In case of inconsistency, the tender documents have precedence over any information presented on this page.